The Toxic Oil Syndrome epidemic that occurred in Spain in 1981 and affected nearly 20,000 people was caused by ingestion of oil mixtures that contained analine-denatured rapeseed oil. To date, an animal model in which to identify the actual etiologic agents(s) and to investigate the pathogenesi s of the disease has not been discovered . In this study, the MRL/lpr was used to assess the histopathologica l response of 3 "toxic oils" and 3 metals. The oils tested were a denatured rapeseed oil collected from a family who were affected by the Toxic Oil Syndrome epidemic in Spain (CO756) plus two synthesized oils (RSD and RSA). Female mice, 7 weeks of age, received an undiluted (neat) or a 1:10 diluted dose of each oil; mercury (50 ppm), cadmium (100 ppm), or lead (50 ppm). Half of each group was killed after 5 weeks of exposure and the remaining mice after 10 weeks of exposure. Body and organ weights (liver, kidney, thymus, and spleen) were recorded and selected organs were collected for histopathology. Ten weeks after treatment, body weights (BW) of the cadmium and lead groups were signi cantly suppressed , and the body weight of the CO756-neat group was signi cantly increased compared to their respective controls. Kidney/BW were decreased in the RSA-neat and RSA 1:10 groups after 10 weeks of exposure, and the kidney/BW in the mercury and cadmium groups were increased. Spontaneous developmen t (12 weeks of age) and progression (17 weeks of age) of histopathologica l lesions are described for selected organs examined in the naṏ ve mice as are changes that resulted from exposure to the "toxic oils" and metals. CO756-neat, mercury, and lead suppressed progression of the glomerulonephriti s that normally occurs in the MRL/lpr mouse. Also of interest were lesions that included mononuclea r cuf ng of hepatic bile ducts, progression of the granulomas that formed in the renal glomeruli, vessels in the lymphoid organs that contained tightly packed lymphocytes , and the presence of plasma cells in the thymus. All 3 oils stimulated early developmen t of the lymphoproliferative syndrome characteristic of the MRL/lpr mouse as demonstrated by an increase in the thymus/BW and spleen/BW ratios after 5 weeks of treatment. These data contribute to our knowledge of spontaneou s disease progression in the thymus, spleen, lymph nodes, and kidneys in the MRL/lpr mouse and the effects of 3 different "toxic oils" and metals on the developmen t and progression of those lesions.
INTRODUCTION
The toxic oil syndrome (TOS) that occurred in Spain in 1981 and caused more than 20,000 cases of illness (300 deaths) occurred as the result of ingestion of rapeseed oil denatured with 2% aniline (1, 13, 15, 19, 25, 27) . Although the compounds responsible for the toxicity have not been de nitively identi ed, there is a strong association between risk of the diseases and 2 different families of compounds found in the oils which came from case families. When the outbreak started, the oleyl anilides were associated with the diseases (5, 18, 28) , but a more detailed analysis of those oils showed that the fatty acid esters 3(N-phenylamino)-1,2-propanediol (PAP) (4, 7, 11, 14, 29, 30) were the best predictors of the case oil. To reconstruct the pathogenesis of this disease, identify the toxic principal(s) responsible for the disease, and to determine the role of the immune system in disease induction and/or progression, development of an animal model representative of the disease in humans would contribute basic information to this process.
There remains an interest today to better understand the etiology and pathogenesis of TOS. Presently, there is not a satisfactory animal model available that emulates the toxic oil syndrome as reported to occur in humans. Thus, the overall objective of the investigation was to ascertain if the MRL/lpr mouse would be an acceptable animal model in which to study mechanisms of the diseases that have been observed in humans as a result of the TOS epidemic. Another goal of the study was to establish baseline reactions in this strain of mouse to speci c toxicants.
A clinical sequelae of TOS was diagnosis of autoimmunelike diseases in a large percentage of the survivors. The etiology of autoimmune disease is considered to be multifactorial requiring genetic susceptibility, which is thought to be triggered by environmental factors and/or infectious agents. Murine animal models such as the NZB/NZW mouse have been used extensively to investigate the pathogenesis of autoimmune disease. The MRL/lpr mouse is a relative "newcomer" to this list of animal models. The MRL/lpr mouse, which is Fas de cient, spontaneously develops a glomerulonephritis, lymphadenopathy, and systemic vasculitis as they age (2, 9, 23, 26, 36 ). The Fas system (Fas/Fas ligand) is instrumental in the pathway of apoptosis (physiological cell death) and controls the balance between lymphocyte life and death (8, 22, 24) . Failure to maintain this balance can lead to autoimmune disease, a mechanism important in the pathogenesis of autoimmune disease in the MRL/lpr mouse. Autoantibodies in this strain of mouse begin to appear spontaneously at 3 months of age and mice die as early as 5 months of age from acute immune complex glomerulonephritis. The MRL/lpr mouse was selected for this study because it spontaneously develops autoimmune disease at an early age and the histopathology has been described primarily for renal lesions and vasculitis, but not extensively for the lymphoid tissue (23, 26, 31, 34, 35, 38) . One goal of this study was to histologically describe lesions that occur spontaneously in the thymus, spleen, and lymph nodes at 12 and 17 weeks of age in the MRL/lpr mouse.
Three metals were included in these studies. Mercury was included primarily to serve as a positive control as mercury induces an immune complex glomerulonephritis in autoimmune genetically susceptible strains of mice, and the effects of mercury on induction and/or progression of lesions in the MRL/lpr mouse are unknown (3, 16, 17) . Cadmium and lead were included for comparison because they both modulate immune responses and are known to be nephrotoxic (12, 20, 21) . Further, cadmium has been reported to induce an autoimmune-like syndrome in experimental animals whereas lead has not (6) .
The 3 oils selected for the investigation were provided by the WHO/CISAT Scienti c Committee for the study of TOS through their general coordinator, co-author Posada. CO756 was documented to come from a family affected during the rst months of the epidemic and is known to contain the aniline contaminants, especially high levels of the phenylaminepropanediol derivatives, thought to be responsible for the syndrome. The second treatment oil (RSA99) was a crude rapeseed oil that was denatured with 2% aniline, but contained no diesters of phenylamine-propanediol. The third oil (RSD99) evaluated was a rapeseed oil denatured with 2% aniline enriched with a mixture of diesters of phenylaminepropanediol. These oils were administered orally to emulate human consumption and 2 doses of each oil (undiluted and 1:10 dilution) were selected in an attempt to demonstrate biological effects (undiluted) and a possible dose response (diluted). The metals (mercury, cadmium, and lead) were administered continuousl y in the drinking water at a predetermined dose, which either induce an autoimmune-like disease (mercury) or produce low toxicity (cadmium and lead). The animals were assessed for selected pathological, toxicological, and immunological effects. The data reported herein from that experiment includes animal body weights, selected organ weights, organ/body weight ratios, and histopathology of selected organs (liver, kidneys, and lymphoid tissue). As such, this report focuses on the pathological and toxicological effects observed in the mice used in the study.
The primary goal of the experiment was to determine if the oils and/or metals were directly toxic (body weights, organ/body weights), to characterize the histopathologica l lesions that spontaneously developed in selected lymphoid organs (thymus, spleen, and lymph nodes), kidneys and liver of the MRL/lpr mouse at 12 and 17 weeks of age, and to identify any change in the severity of those lesions produced by the test agents over time (5 and 10 weeks of exposure). Although considerable immunological information has been acquired for the MRL/lpr mouse, the induction and/or progression of lesions in the lymphoid organs have yet to be adequately described.
METHODS

Mice:
Female MRL/lpr mice were purchased from the Jackson Laboratory, Bar Harbor, ME. Animals were main-tained on a 12-h light/dark cycle at 22 2 C, housed in polycarbonate cages, and given Harlan Tekland rodent diet and tap water ad libitum. All mice were 7 weeks of age at the onset of treatment.
Animal Treatment: Twenty mice in each group were gavaged 3 times per week (0.25 ml/mouse) with either 3 different toxic oil compounds (RSD 99, RSA 99, and CO756; courtesy of Posada) or a canola oil control. Each test agent was administered at 2 different doses, undiluted (neat) and at a 1:10 dilution made in canola oil for a total of 7 treatment groups. CO756 is an oil that came directly from a family affected during the TOS epidemic (containing high levels of phenylamine-propanediol derivatives and was subsequently re ned following the methods used in the re nery implicated in the epidemic). RSA 99 is a crude rapeseed oil denatured with 2% aniline (contains high level of anilides, no diesters of phenylamine-propanediol), and RSD 99 is a rapeseed oil denatured with 2% aniline, which after re ning, was enriched with a mixture of diesters of phenylamine-propanediol. Four additional groups of mice were treated with either mercuric chloride (50 ppm), cadmium chloride (100 ppm), lead acetate (50 ppm) (Sigma Chemical Co, St. Louis, MO), or a naṏ ve control (untreated tap water). Chemical agents were administered continuously in the drinking water. Mice were weighed weekly for all treatments.
Pathology: Ten mice from each group were killed after 5 weeks (12 weeks of age) and the remaining 10 mice after 10 weeks (17 weeks of age) of treatment. At necropsy, animals were weighed and sections of selected tissues and organs (liver, kidneys, heart, lungs, spleen, thymus, lymph nodes, pancreas, stomach, intestine, and adrenal glands) were collected for future histopathological examination. Samples were xed in 10% buffered formalin and subsequently sectioned (5 l m) and stained with hematoxylin and eosin. Selected organs (liver, kidneys, thymus, and spleen) were also weighed at necropsy.
Statistics: Body weights at necropsy and selected organ weights (liver, kidney, thymus, and spleen) as expressed as a percentage of body weight were analyzed for statistical signi cance using an ANOVA (Statgraphics, STSC, Inc, Rockville, MD; version 5.0). Differences with a p < 0.05 were considered signi cant between treatment and respective controls. Differences of p < 0.1 were also noted.
RESULTS
Body and Organ Weights
Compared to the canola oil control, the body weights after 5 weeks of treatment were signi cantly ( p < 0.05) reduced for the RSD neat and CO756 1:10 groups (Table 1) . At the end of the "feeding" trial (10 weeks), the body weights were increased for the CO756 neat ( p < 0.05), RSD neat ( p < 0.1), and RSA 1:10 ( p < 0.1) groups compared to the canola oil control ( Table 2 ). The body weights of the mercury, cadmium, and lead groups were signi cantly ( p < 0.05) suppressed both after 5 and 10 weeks of treatment compared to the naṏ ve control except mercury was reduced at p < 0.1 signi cance at 10 weeks.
After 5 weeks of exposure, the liver to body weight ratios (/BW) was signi cantly ( p < 0.05) increased in the RSD neat group compared to the canola oil control ( Table 1 ). There were no signi cant differences at p < 0.05 noted for the liver/BW of the test oils compared to the canola oil control at 10 weeks except for an increase at p < 0.1 in the RSD 1:10 group ( Table 2 ). The liver/BW was signi cantly ( p < 0.05) increased in the cadmium treated group after 10 weeks of exposure. The kidney /BW were similar for all of the oil groups (test agents and controls) after 5 weeks of exposure while the three metals kidney/BW were all signi cantly ( p < 0.05) increased compared to all other groups ( Table 1 ). After 10 weeks of treatment, the kidney/BW for RSA neat ( p < 0/1) and RSA 1:10 ( p < 0.05) were signi cantly decreased compared to the canola oil control whereas the kidney/BW were signi cantly increased in the mercury ( p < 0.05) and cadmium ( p < 0.1) group compared to the naṏ ve controls ( Table 2 ).
The thymus/BW increased signi cantly after 5 weeks of treatment in the RSD neat ( p < 0.05), RSA 1:10 ( p < 0.05), CO756 neat ( p < 0.1), and CO756 1:10 ( p < 0.05), groups compared to the canola oil control ( Table 1 ). The thymus/BW increased ( p < 0.05) in the lead group compared to the naṏ ve control at 5 weeks (Table 1) . At 10 weeks, however, there were no signi cant differences noted in the thymus/BW comparing the treatment groups to their respective control ( Table 2 ). The spleen/BW patterns were somewhat similar after 5 and 10 weeks of treatment. The spleen/BW were signicantly ( p < 0.05) increased at week 5 for groups RSD neat, RSD 1:10, CO756 neat, and CO756 1:10 and increased ( p < 0.1) for RSA neat compared to the canola oil control (Table 1) . At 10 weeks, the spleens were signi cantly ( p < 0.05) enlarged in the RSD 1:10, RSA neat, CO756 neat, CO756 1:10, and the RSD 1:10 ( p < 0.1) groups compared to canola oil controls ( Table 2 ). The spleen/BW increased ( p < 0.05) in the 10-week cadmium group compared to the naṏ ve control.
Histopathology 12 Weeks of Age-5 Weeks of Exposure
Naṏve Control: In the liver, there was some variation in size of hepatocytes. The hepatocytes in many of the lobules were mildly to moderately enlarged in centrolobular to midzonal areas. All hepatocyte cytoplasms were moderately vacuolated resembling hydropic change.
The architecture of the kidney in the 12-week-old MRL/lpr mice ranged from near normal to "moderate" lesions. The glomeruli frequently varied in size, some were enlarged while others were atrophic. There was mild-to-moderate Granulomas, characterized by accumulation of mononuclear cells, initially formed at the vascular pole of the glomerulus (Figure 1 ). In some glomeruli, the cells invaded the glomerular tufts. These were in the "early stages" of development. An infrequent microgranuloma was observed in the renal interstitium of the cortex. In some of the larger glomeruli, Bowman's space was obliterated and Bowman's capsule slightly thickened. There was slight (very early) vacuolation of the proximal convoluted tubule epithelium immediately subcapsular in the cortex. Large accumulations of mononuclear cells (primarily lymphocytes) were located on the exterior surface of the renal pelvis facing the renal sinus and frequently surrounding the larger renal arteries and veins ( Figure 2 ). An occasional larger artery in the cortex was "cuffed" (moderate thickness) by mononuclear cells (mainly lymphocytes). Microgranulomas were rarely observed adjacent to veins in the cortex.
The majority of the spleens (65-75%) were composed of large round coalescing nodules that contained medium stained (basophilic), round lymphocytes of medium-to-small (immature to mature) size. Cells in mitosis were dispersed among the lymphoid cells. The red pulp, distinguished at the periphery of the spleen (mostly subcapsular), was composed mainly of cells of hematopoiesis (megakaryocytes and small dark basophilic round cells) with the sinusoids containing erythrocytes.
The microstructure of the thymus varied considerably from near normal to an extensive round cell in ltrate. In the least effected thymuses, the cortex and medulla were normal except for a moderate hypercellularity of the medulla consisting of a mixture of small, dark, round cells (mature) and medium stained, medium sized, round-to-oval cells (immature). In the most severely affected thymuses, the normal architecture was almost unrecognizable with very little visible cortex. Almost the entire thymus appeared more like medulla, composed of sheets of loosely packed round cells with a diffuse scattering of large round, pale mononuclear cells in the center of the lobules. Many of the blood vessels were tightly packed with dark, basophilic round cells (lymphocytes).
Most all lymph nodes examined (axillary, mesenteric, and iliac) were composed of a diffuse sheet of a mixture of medium-stained and medium-sized to smaller and darker (basophilic) round cells (lymphocytes). "Lymphoid nodules" were usually obscure. In an occasional node, there were "nodules" of densely packed dark (purple-blue) cells of uniform (medium) size that resembled lymphoblasts ( Figure 3 ). In these areas, blood vessels were lled with tightly packed, deeply basophilic, small round cells (lymphocytes). A small "collection" of plasma cells was present in the most severely affected nodes. Mitotic gures were present in all lymph nodes. The mesenteric lymph nodes appeared to be those most severely affected of the lymph nodes examined.
Mercury: In the mercury (50 ppm) group, the hepatocytes were mostly uniform in size and there was a slight-tomild hydropic change. No lymphocyte in ltrate was noted in the portal triads. The changes in the kidneys were similar to the naṏ ve control except there were more glomeruli with a thickened Bowman's capsule, and granuloma formation was not as obvious in the kidneys of the mercury-treated mice; for example, microfoci at the vascular pole of the glomeruli and in the cortical interstitium were infrequent. Lesions in the other organs (spleen, thymus, and lymph nodes) resembled changes noted for the naṏ ve control.
Cadmium and Lead: The lesions in organs examined of the cadmium (100 ppm) and lead (50 ppm) treated groups were similar to those described for the naṏ ve control.
Canola Oil: Canola oil treatment did not result in any histopathology in the organs examined different from those seen in the naṏ ve controls except for a mild lymphocytic in ltration in an infrequent portal triad. The lymphocytes usually "cuffed" the bile ducts. Most of the kidneys in this group were more normal in appearance.
RSD: In the RSD neat group, a lymphocyte in ltrate was present in an occasional portal triad, particularly surrounding the bile ducts. The kidneys were similar to the controls with little evidence of granuloma formation at the glomerular vascular pole or in the cortical interstitium. The other tissues were similar to the naṏ ve control. The RSD 1:10 group had lesions similar to the naṏ ve control.
RSA: Lesions in the RSA neat and RSA 1:10 groups were similar to the naṏ ve control. However, glomerular granuloma formation was minimal.
CO756: Lesions in the CO756 neat and CO756 1:10 groups were similar to the naṏ ve control for all tissues.
Histopathology 17 Weeks of Age-10 Weeks of Exposure
Naṏve Control: The hepatocytes in the liver were mostly uniform in size with some cells enlarged midzonal. The cytoplasm of the hepatocytes was vacuolated (mild to moderate) resembling hydropic change. A very small mononuclear cell in ltrate was observed in an occasional portal triad. These cells were primarily lymphocytes with occasional plasma cells, which frequently "cuffed" the bile ducts ( Figure 4 ). The hydropic change was less at 17 weeks of age than noted at 12 weeks of age whereas the mononuclear cell in ltrate in the portal triads was obvious at 17 weeks, but not at 12 weeks of age.
There was considerable variation between individual mice in the degree of lesions in the kidneys at 17 weeks of age. These ranged from mild (none to early granuloma formation and perivascular cuf ng) to severe effects. In the more severely affected mice, the glomeruli varied in size. Several were atrophic, yet others were enlarged. There was moderate proliferation of mesangeal cells and proliferation of the capillary tufts in the larger glomeruli. An occasional "crescent" was observed. Granulomas of various stages appeared to begin forming at the vascular pole of the glomeruli with some invading the glomeruli, infrequently destroying them. Bowman's capsule was thickened in those glomeruli and occasionally in others. Multifocal microgranulomas consisting primarily of histocytes and lymphocytes were present in the interstitium of the renal cortex. A mild-to-moderate vaculolation of the subcapsular proximal convoluted tubule epithelium was observed. Many arteries were surrounded (cuffed) by thick accumulations of primarily lymphocytes, less frequently plasma cells, and occasionally histocytes. In an occasional artery, these cells penetrated the arterial wall, some revealed by hypercellularity of the media, others destroyed a segment of the entire arterial wall, and others were completely occluded by a granuloma. The exterior wall of the renal pelvis facing the renal sinus was lined by a thick collection of a mixture of mononuclear cells, primarily lymphocytes.
The changes in the spleen ranged from nodules of lymphocytes to coalescing nodules forming con uent "sheets" of cells. The lymphocytes were darker (basophilic) stained and more consistent in size (small) in the spleens that had the most white pulp that ranged from approximately 50-75% of the splenic tissue. Mitotic gures were present. In the most severely affected spleens, an infrequent "collection" of plasma cells was present in the white pulp. The red pulp consisted mostly of cells of hematopoiesis, but blood-lled sinusoids were visible.
Small areas of the thymus in some mice appeared to be normal accept for hypercellularity of the medulla. However, most of the thymuses had a very thin to no cortex with the majority of the tissue appearing as a solid sheet of moderately dense, medium-to-dark (basophilic) stained, small-tomedium sized, round cells (thymocytes/lymphocytes). Some blood vessels were tightly packed with dark (basophilic) stained lymphocytes. An occasional "cluster" of plasma cells was observed.
Most lymph nodes were composed of solid sheets of lymphocytes varying in density and staining characteristics. The least dense nodes contained medium to darker stained (basophilic) lymphocytes, and the most dense nodes were composed of small very dark lymphocytes. In the most dense nodes (usually mesenteric), nodules of densely packed dark (purple-blue) lymphocytes of uniform (medium) size were observed. In most nodes, the blood vessels were tightly packed with extremely dark, small lymphocytes. Mitotic gures were observed in all lymph nodes.
Mercury (50 ppm):
The lesions in the kidneys of the mercury group were overall mild compared to those observed in the naṏ ve control; eg, less granuloma formation and perivascular deposits of mononuclear cells. The larger glomeruli, however, had marked proliferation of mesangeal cells and thickened capillary tufts. The lesions in the other organs (liver, spleen, thymus, and lymph nodes) were similar to those noted in the naṏ ve control.
Cadmium (100 ppm):
The lesions in the kidneys of the cadmium-treated mice were similar to those in the naṏ ve control except there was less perivascular cuf ng noted in the cadmium-exposed group. The lesions in the liver, spleen, thymus, and lymph nodes were similar to those found in the naṏ ve control.
Lead (100 ppm): The kidneys in the lead-treated group were more "normal-like" compared to the changes observed in the kidneys of the naṏ ve control. There was minimal variation in glomerular size, a mild increase in mesangeal cells, very little capillary proliferation, and granulomas were infrequent and in the early stage of development. In an occasional mouse, early granuloma formation was present at the vascular pole of the glomeruli. Perivascular cuf ng was also absent in many kidneys, yet others had a mild accumulation of lymphocytes. The renal pelvic in ltrate of lymphocytes was also minimal in these mice compared to the naṏ ve controls. The lesions in the lymph nodes of the leadtreated mice were also less severe than those in the naṏ ve control. The white pulp consisted mostly of a solid sheet of medium-stained small lymphocytes and did not contain the densely packed dark (purple-blue) cells noted in the lymph nodes of the naṏ ve control and other treatment groups. The lesions in the liver, spleen and thymus were similar to the naṏ ve control.
Canola Oil: The hepatocytes in a few livers of the canola oil treated mice were enlarged, some quite large, in the midzonal region of the lobule. The other lesions in the liver (hydropic change and mononuclear cell in ltrate in the portal triads) were similar to these noted in the naṏ ve control. The lesions in the kidneys, spleen, thymus, and lymph nodes of the canola-oil-treated group were similar to those described for their respective organ in the naṏ ve control.
RSD: The lesions in the livers of the RSD neat and RSD 1:10 groups were similar to those in the naṏ ve control except the portal triads in the RSD neat group were free of mononuclear cells. The lesions in the kidneys, spleen, thymus, and lymph nodes were comparable between the RSD neat, RSD 1:10, and naṏ ve control.
RSA:
The lesions in the liver, kidneys, spleen, thymus, and lymph nodes were similar to those observed in the naṏ ve control except the portal triads in the livers of the RSA neat and RSA 1:10 groups did not contain a mononuclear cell in ltrate as noted in the naṏ ve control.
CO756: Except for the lack of a mononuclear cell inltrate in the portal triads of the liver of the CO756 group, the lesions in the liver of the CO756 neat and CO756 1:10 were similar to the naṏ ve control. The kidneys in the CO756 neat group were overall more normal in appearance. A mildto-moderate hyperplasia of mesangeal cells was observed and an occasional glomeruli had a thickened Bowman's capsule. There was a noticeable lack of granuloma formation in the glomeruli (very early in frequent formation at vascular pole) and interstitium. The larger arteries (and renal pelvis) were cuffed by a large collection of primarily lymphocytes and less numerous plasma cells and histocytes. The changes in the spleen of the CO756-neat group were similar to the naṏ ve control although some spleens were composed primarily ( 90%) of coalescing nodules containing small-, medium-, to dark-stained lymphocytes. The lesions in the thymus and lymph nodes of both the CO756-neat and CO756 1:10 groups were similar to those described for the naṏ ve control.
DISCUSSION
The oils evaluated in this study were selected and provided by the WHO/CISAT Scienti c Committee for the Study of the Toxic Oil Syndrome. Investigations have been conducted in an attempted to identify the individual chemicals within the aniline contaminant that was responsible for the disease that occurred in humans. In 1 study (28) , it was determined that the TOS cases occurred in families consuming oil with more than 825 l g/L of oleyl anilide, which suggested that this compound was the causal agent of TOS. Other studies have suggested that 3-(N-phenylamino-1,2 propanediol (PAP) is strongly associated as the etiologic agent of TOS (4, 7, 11, 30, 33) . Three oils were evaluated in the current study, 2 that contained PAP (CO756 and RSD99) and one that did not (RSA99). Histopathology focused primarily on the lymphoid organs (thymus, spleen, and lymph nodes) and the kidneys because lymphoproliferative disease develops spontaneously in the MRL/lpr mouse and the objective of the overall study was to determine if the oils and metals induced and/or exacerbated autoimmune disease in this mouse model. Further, a histopathologica l description of the lymphoid organs is limited for the MRL/lpr mouse, especially as the spontaneous disease progresses. Therefore, to be able to understand the pathological effects of the oils and metals, it was essential to determine the "normal" pathology of the tissue and organs to identify any effects that were induced, or impaired by the test agents. This manuscript presents that data as well as the effects the test agents had on body and organ weights.
It is noteworthy that in the toxic oil groups when the test oils were compared to the canola oil control, the body weights were decreased at 5 weeks in the RSA neat and CO756 1:10 groups but increased for the CO756 group at 10 weeks. Thus, when the body weight of the test oil groups were compared to their vehicle control (canola oil) at termination of the "feeding trial," toxic effects expressed as reduced weight were not produced by the test oils. The body weights of the three metals; however, were signi cantly decreased compared to the naṏ ve control at both 5 and 10 weeks of exposure.
An unexpected result was the signi cant ( p < 0.05) decrease in body weights of the canola oil control compared to the naṏ ve control after 10 weeks of treatment. Scientists are cautioned that a treatment vehicle by itself may affect the toxicodynamics of a test agent and produce biological effects. In a recent study (32) , the body weights of Sprague-Dawley rats were signi cantly reduced when gavaged daily for approximately 6 weeks with 10 ml/kg corn oil, a commonly used treatment vehicle. In our study, mice were gavaged 3 times per week with approximately 8 ml/kg canola oil. However, 4 of the test oil treatments (RSD neat, RSA 1:10, CO756 neat and CO756 1:10), which were composed primarily of canola oil, demonstrated body weights not signi cantly different from the naṏ ve control. This might suggest an inhibitory or suppressive effect of the contaminants present in the toxic oil compounds tested in relation to the reduced weight gain of the canola oil controls.
There was no consistent pattern in the organ/body weights of the test oils following 5 and 10 weeks of exposure when compared to the canola oil control. In the RSD group, the liver/BW were increased at 5 weeks (neat), thymus/BW increased at 5 weeks (neat) and spleen/BW increased at both 5 weeks (neat and 1:10) and 10 weeks (1:10) of treatment. In the RSA group, kidney/BW was decreased at 10 weeks (neat and 1:10), thymus/BW increased at 5 weeks (1:10), and the spleen/BW increased at 5 weeks (neat) and 10 weeks (neat). For the CO756 group, thymus/BW was increased at 5 weeks (neat and 1:10) and the spleen/BW increased both after 5 weeks (neat and 1:10) and 10 weeks (neat and 1:10) of exposure. The only consistent "dose effect" changes of organ/body weights at 10 weeks were a decrease in the kidney/BW in the RSA groups (neat and 1:10) and increase in the spleen/BW in the CO756 groups (neat and 1:10). However, the spleen/BW in all of the test oil groups were greater (nonsigni cant) than either the naṏ ve or canola oil controls suggesting that the oils may have enhanced the lymphoproliferative response that spontaneously occurs in this organ. There was a signi cant increase in the kidney/BW in both the mercury-and cadmium-treated mice compared to the naṏ ve control after 5 and 10 weeks of treatment and in the leadtreated mice at 5 weeks. These metals are known for their renal toxic properties. The liver and spleen weights were also increased in the cadmium mice exposed for 10 weeks suggesting that the 100 ppm dose resulted in systemic toxicity.
The MRL/lpr mice spontaneously develop a glomerulonephritis, lymphadenopathy, and systemic vasculitis as they age (2, 9, 23, 26, 36) . However, most histopathology has been selectively described for renal lesions and the later stages of vasculitis in the disease process (23, 26, 31, 34, 35, 38) . Although a primary objective of this study was to evaluate the histopathologica l deviations of selected organs in this strain of mouse produced by "toxic oils" and selected metals, a secondary goal was to describe the histopathology of these organs at an early age (12 and 17 weeks) as the spontaneous disease develops and progresses. Because the MRL/lpr mouse is Fas de cient, which impairs apoptosis, and a lymphoproliferative disease develops, the pathology focused primarily on the kidney (glomerulonephritis ) and lymphoid organs; eg, thymus, spleen, and lymph nodes. The liver was also examined histologically.
The liver lesions in the naṏ ve controls at 12 and 17 weeks of age were rather consistent. The mild-to-moderately enlarged hepatocytes (centrolobular to midzonal) resembled effects noted in some chemical-induced hepatotoxicities, such as polyhalogenated aromatic hydrocarbons, and obviously occurred at a very early age ( > 12 weeks). The unique feature of the mononuclear in ltrate in the portal triads at 17 weeks of age was their location; eg, frequently cuf ng the bile ducts rather than the blood vessels. In addition, the in ltrate (lymphocytes) occasionally contained plasma cells. Further, in the canola oil control, this lesion was noted earlier (12 weeks of age, 5 weeks of treatment) yet in the undiluted (neat) test oils (RSD, RSA, and CO756), this in ltrate was absent, even at 17 weeks of age (10 weeks of treatment). Because this lesion was only a mild effect in the two control groups (naṏ ve and canola oil), and although it was an unusual nding, it was not considered to be a signi cant change. However, it is possible that these oils may inhibit, albeit slightly, the chemo-tactic activity of lymphocytes even though the bile ducts were the vessels that were "cuffed." Further studies are warranted to understand the mechanism responsible for this unusual lesion.
The range of gradation of lesions in the kidneys of the naṏ ve controls at both 12 and 17 weeks of age could represent variation at the age spontaneous disease developed and subsequent progression of the glomerulonephritis syndrome in "individual" mice. It is noteworthy that by 12 weeks of age, some of these mice displayed signi cant hyperplasia of glomerular mesangeal cells and endocapillary proliferation, microglanulomas of the glomerulus and cortical interstitium, and large accumulations of mononuclear cells perivascular. Although vasculitis is a common lesion in the MRL/lpr mouse (23, 26) , the extent of these lesions in the kidneys varied from mouse to mouse, and the most notable effect was the large accumulations of mononuclear cells (primarily lymphocytes) located on the exterior surface of the renal pelvis facing the renal sinus. This extravasation most likely was associated with the renal artery. Further, the arteries in this region of the kidney were those rst to show lesions of "arteritis" in the tissues/organs examined in this study.
Another observation in the kidneys was progression of granulomatous disease. The granulomas were observed to initially form at the vascular pole of the glomerulus before invading the glomerular tufts. Microgranulomas appeared to form later in the cortical interstitial tissue than in the glomeruli. These lesions were more severe in the mice 17 weeks of age in which an occasional glomerulus was destroyed (replaced) by a granuloma.
The kidney lesions in the oil-treated mice were similar to those noted in the naṏ ve and canola oil controls except they were less severe in the CO756 neat group. The kidneys in the CO756 neat group after 10 weeks of exposure (17 weeks of age) appeared to be more "normal-like" and in particular, had a noticeable lack of granuloma formation, which was rather extensive in the other groups, except for the lead and mercury groups, which were slightly more pronounced than in the CO756 group. The mechanism responsible for these "protective effects" are unknown and were unexpected in the mercury-exposed group particularly because mercury is known to induce an immune complex glomerulonephritis in autoimmune genetically susceptible mice (3, 16, 17) .
There was considerable lymphoproliferation noted in the spleen, thymus, and lymph nodes at 12 weeks of age, which was extensive at 17 weeks of age. The increase in spleen weights noted for all 3 test oils (neat or 1:10) at necropsy could not be differentiated from the controls histopathologically due to the extensive proliferation of densely packed lymphocytes in the spleens of the naṏ ve and canola oil controls. There were some interesting lesions, however, observed in the lymphoid organs. First, as expected, the lymph nodes were composed of solid sheets of lymphocytes that were extremely dense, both in depth and breadth. However, frequently found within those nodes were nodules of densely packed dark (purple-blue) lymphocytes of uniform (medium) size. Those cells were perhaps a particular form of an immature (differentiating lymphoblasts) lymphocyte. Secondly, many vessels in the lymphoid organs were tightly packed, possibly occluded, with small dark basophilic round cells (lymphocytes). That lesion was more obvious at 17 weeks of age. Third, plasma cells were occasionally identi ed in all of the lymphoid organs examined, a cell that is not commonly found in the thymus. It is possible that those cells were producing antibodies to autoantigens because several autoantibodies develop spontaneously in the MRL/lpr mouse (9, 10, 36) . Fourth, the absence of polymorphonuclea r cells in those organs would suggest a lack of invasion by "septic" organisms. Finally, of the lymphoid organs examined, the mesenteric lymph nodes appeared to be those most severely affected at 12 weeks of age, which is in keeping with the concept that vasculitis initially occurs in the mesenteric vessels. A signi cant difference in development of the lymphoproliferative disease in the oil and metal groups could not be distinguished histologically from the naṏ ve or canola oil control due to the extensive proliferation of lymphocytes in the lymphoid organs of the controls.
The renal lesions in the MRL/lpr mice as they age are similar to those produced by mercury in genetically susceptible mice (3, 16, 17) . However, in this study, the renal lesions were less severe in the mercury treated MRL/lpr mouse than in age-matched naṏ ve controls, an unexpected nding. Glomerular lesions have been reported to be less severe in MRL/lpr mice de cient in the IFN-c receptor gene (38) , or CD28 gene (31), by blocking nitric oxide (37) , or when injected with G-CSF (35) . It is obvious that several different mechanisms may be involved in the development and/or progression of glomerulonephritis. Thus, the mechanism(s) responsible for the milder renal lesions noted in CO756-neat, mercury-, and lead-exposed mice could differ because there could be different pathways involved in development and/or progression of glomerulonephritis.
There was evidence in these studies that the oils, as a group, stimulated early development of the naturally occurring lymphoproliferative disease in these mice because at 5 weeks of exposure there was a signi cant increase in both the thymic and splenic weights although an increase in cellularity could not be delineated by histopathology. On the other hand, the metals did not appear to potentiate the natural occurring lymphoproliferative disease, except that lead increased the thymus/BW at 5 weeks. These differences, however, also could not be discerned by histopathology.
There did not appear to be a direct relationship between development of glomerulonephritis and signi cant effects in organ/BW. The kidney/BWs were signi cantly greater for the 3 metals at 5 and 10 weeks (except lead at 10 weeks) of exposure compared to the naṏ ve control. The renal lesions were milder in the mercury and lead groups at 10 weeks compared to the naṏ ve control, yet the cadmium lesions were similar to the controls. Further, the least severe lesions were noted in the CO756-neat group that had kidney/BWs comparable to the controls, the RSA neat and 1:10 groups had signi cantly reduced kidney/BWs with no signi cant difference in lesions. Thus, the toxicity data was not predictive of the histopathologica l differences noted in the kidneys for the CO756, mercury, or lead groups compared to their respective control.
The primary goal of this experiment was to assess the effects of the metals and toxic oils on the immune system and lymphoid organs of the MRL/lpr mouse. Because this mouse develops idiopathic autoimmune disease and a systemic vasculitis at an early age, it was not our intent to ascertain if the pathology that occurred emulated the pathology as seen in humans exposed to these test agents, but rather, to determine if the test agents would induce, exacerbate, accelerate, and/or produce atypical disease that occurs spontaneously in the MRL/lpr mouse. Some of these agents (mercury, lead, and CO756) did alter normal progression of the histopathological lesions in this mouse model. Another goal of the study was to determine if exposure to the 3 oils resulted in different effects in the toxicological parameters evaluated. Although toxicological effects were observed compared to the canola oil control, there were no signi cant differences in those effects between the three oil exposure groups.
In summary, there was evidence that the 3 oils stimulated development of the lymphoproliferative disease that spontaneously occurs in the MRL/lpr mouse, whereas one oil markedly suppressed the progression of renal pathology. On the other hand, the 3 metals did not appear to affect the lymphoproliferative process, but they did increase the kidney/BWs and 2 of them, mercury and lead, also suppressed spontaneous development of the renal lesions, an unexpected but interesting nding. This study describes the "natural" histopathologica l progression of lesions in selected organs at 2 different ages (12 and 17 weeks) in the MRL/lpr mouse and the effects of 3 different "toxic oils" and metals on the development and progression of those lesions. These data, coupled with the autoimmune data (manuscript in preparation) collected from this study, indicated that the MRL/lpr mouse can be considered as an acceptable model to assess the autoimmune potential of chemicals. However, future investigations must focus on characterizing progression (kinetics) of the "normal" immune response in this mouse to be able to identify any chemical induce abnormalities that may occur in those patterns.
